Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with

Amy C Justice1, Kathleen A McGinnis2, Janet P Tate1

  • 1Veterans Aging Cohort Study Coordinating Center, West Haven VA Healthcare System, 950 Campbell Ave, West Haven, CT 06516, USA; Department of Internal Medicine, and the Center for Interdisciplinary Research on AIDS (CIRA), Yale School of Medicine, Yale University 367 Cedar Street, New Haven, CT 06510, USA.

Drug and Alcohol Dependence
|February 11, 2016
PubMed

Insights

HIV-infected individuals face higher mortality and injury risks from alcohol use, even with treatment. Lower alcohol consumption limits are recommended for those with HIV.

Area of Science:

  • Medical Research
  • Public Health
  • Infectious Diseases

Background:

  • Individuals with Human Immunodeficiency Virus (HIV) may be more vulnerable to alcohol-related health issues than those without HIV.
  • Antiretroviral therapy (ART) has improved outcomes for HIV-positive individuals, but co-occurring conditions like alcohol use disorders remain a concern.

Purpose of the Study:

  • To investigate the differential impact of alcohol consumption on mortality and physiological injury in HIV-positive versus HIV-uninfected individuals.
  • To determine specific alcohol consumption thresholds associated with adverse outcomes in both HIV-positive and HIV-uninfected populations.

Main Methods:

  • Analysis of data from the Veterans Aging Cohort Study (VACS) including HIV-positive and HIV-uninfected participants.
  • Utilized Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) scores and Cox proportional hazards models for mortality analysis.
  • Employed linear regression models to assess physiological injury using VACS Index Scores, adjusting for covariates like age, race, smoking, and hepatitis C infection.

Main Results:

  • The study included 18,145 HIV-positive and 42,228 HIV-uninfected individuals.
  • Lower alcohol consumption levels (AUDIT-C score ≥4 or ≥30 drinks/month) were associated with increased mortality risk in HIV-positive individuals compared to HIV-uninfected individuals (AUDIT-C score ≥5 or ≥70 drinks/month).
  • Physiological injury was linked to lower AUDIT-C scores in HIV-positive individuals (scores 5-7) versus HIV-uninfected individuals (score ≥8).

Conclusions:

  • HIV-positive individuals experience greater mortality and physiological harm from alcohol use, even when on ART, compared to their HIV-uninfected counterparts.
  • Recommended alcohol consumption limits should be lower for HIV-positive individuals to mitigate health risks.
  • These findings underscore the importance of tailored alcohol use guidelines for vulnerable populations in HIV care.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Hypothesis Test for Test of Independence01:16

Hypothesis Test for Test of Independence

The test of independence is a chi-square-based test used to determine whether two variables or factors are independent or dependent. This hypothesis test is used to examine the independence of the variables. One can construct two qualitative survey questions or experiments based on the variables in a contingency table. The goal is to see if the two variables are unrelated (independent) or related (dependent). The null and alternative hypotheses for this test are:
H0: The two variables (factors)...
8.4K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
335
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
333
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.6K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
256